https://www.reforms-project.org.uk/clinical-trial/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/dasatinib-ifosfamide-carboplatin-and-etoposide-in-treating-young-patients-with-metastatic-or-recurrent-malignant-solid-tumors/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/iodine-i-131-monoclonal-antibody-3f8-in-treating-patients-with-central-nervous-system-cancer-or-leptomeningeal-cancer/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/study-to-assess-safety-and-preliminary-activity-of-eribulin-mesylate-in-pediatric-participants-with-relapsed-refractory-rhabdomyosarcoma-rms-non-rhabdomyosarcoma-soft-tissue-sarcoma-nrsts-and-ewi/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/taa-specific-ctls-for-solid-tumors-tactasom/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/busulfan-melphalan-topotecan-hydrochloride-and-a-stem-cell-transplant-in-treating-patients-with-newly-diagnosed-or-relapsed-solid-tumor/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-haploidentical-transplantation-with-post-transplant-cyclophosphamide-and-prophylactic-donor-lymphocyte-infusions/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-ii-study-of-irinotecan-and-gemcitabine-in-pediatric-adolescent-and-young-adult-patients-with-relapsed-or-refractory-solid-tumors/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/vincristine-and-temozolomide-in-combination-with-pen-866-for-adolescents-and-young-adults-with-relapsed-or-refractory-solid-tumors/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/interleukin-15-and-21-armored-glypican-3-specific-chimeric-antigen-receptor-expressed-in-t-cells-for-pediatric-solid-tumors/ 2026-06-04T16:23:26+00:00 https://www.reforms-project.org.uk/clinical-trial/a-pilot-study-of-thermodox-and-mr-hifu-for-treatment-of-relapsed-solid-tumors/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/b7-h3-specific-chimeric-antigen-receptor-autologous-t-cell-therapy-for-pediatric-patients-with-solid-tumors-3car/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/temokids-study-orp-tmz-i-b-a-population-pharmacokinetic-acceptability-and-safety-study-for-kimozo-a-paediatric-oral-suspension-of-temozolomide/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/cotesarc-a-multicentre-phase-i-ii-study-evaluating-the-combination-of-a-mek-inhibitor-and-a-pdl1-inhibitor-in-pediatric-and-adult-patients-with-locally-advanced-and-or-metastatic-soft-tissue-sarcoma/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-bempegaldesleukin-bempeg-nktr-214-in-combination-with-nivolumab-in-children-adolescents-and-young-adults-with-recurrent-or-treatment-resistant-cancer-pivot-io-020/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-1-multicentre-open-label-dose-escalation-and-cohort-expansion-study-of-niraparib-and-dostarlimab-in-paediatric-patients-with-recurrent-or-refractory-solid-tumours/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/inform2-study-uses-nivolumab-and-entinostat-in-children-and-adolescents-with-high-risk-refractory-malignancies/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/auto-transplant-for-high-risk-or-relapsed-solid-or-cns-tumors/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/b7h3-car-t-cell-immunotherapy-for-recurrent-refractory-solid-tumors-in-children-and-young-adults/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/donor-stem-cell-transplant-after-chemotherapy-for-the-treatment-of-recurrent-or-refractory-high-risk-solid-tumors-in-pediatric-and-adolescent-young-adults/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/egfr806-car-t-cell-immunotherapy-for-recurrent-refractory-solid-tumors-in-children-and-young-adults/ 2026-06-04T16:23:27+00:00 https://www.reforms-project.org.uk/clinical-trial/dose-escalation-study-of-clr-131-in-children-adolescents-and-young-adults-with-relapsed-or-refractory-malignant-tumors-including-but-not-limited-to-neuroblastoma-rhabdomyosarcoma-ewings-sarcoma-a/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/interleukin-15-armored-glypican-3-specific-chimeric-antigen-receptor-expressed-in-t-cells-for-pediatric-solid-tumors/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-study-of-olaparib-and-temozolomide-for-ewings-sarcoma-or-rhabdoomyosarcoma/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-onivyde-with-talazoparib-or-temozolomide-in-children-with-recurrent-solid-tumors-and-ewing-sarcoma/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/vorinostat-in-combination-with-chemotherapy-in-relapsed-refractory-solid-tumors-and-cns-malignancies-nymc195/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/sirolimus-in-combination-with-metronomic-chemotherapy-in-children-with-recurrent-and-or-refractory-solid-and-cns-tumors-aflacst1502/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-palbociclib-combined-with-chemotherapy-in-pediatric-patients-with-recurrent-refractory-solid-tumors/ 2026-06-04T16:23:28+00:00 https://www.reforms-project.org.uk/clinical-trial/safety-tolerability-efficacy-and-pharmacokinetics-of-copanlisib-in-pediatric-patients/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/sarc024-a-blanket-protocol-to-study-oral-regorafenib-in-patients-with-selected-sarcoma-subtypes/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/nab-paclitaxel-and-gemcitabine-for-recurrent-refractory-sarcoma/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/nab-paclitaxel-in-combination-with-gemcitabine-for-pediatric-relapsed-and-refractory-solid-tumors/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/mocetinostat-with-vinorelbine-in-children-adolescents-young-adults-with-refractory-and-or-recurrent-rhabdomyosarcoma/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/heated-intra-peritoneal-chemotherapy-with-doxorubicin-and-cisplatin-for-abdominal-for-pelvic-tumors-in-pediatric-patients-toastit/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-abemaciclib-ly2835219-in-combination-with-other-anti-cancer-treatments-in-children-and-young-adult-participants-with-solid-tumors-including-neuroblastoma/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/anti-angiogenic-therapy-post-transplant-ascr-for-pediatric-solid-tumors-ascr/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/abemaciclib-in-children-with-dipg-or-recurrent-refractory-solid-tumors-aflacst1501/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/alpha-beta-cd19-depleted-haploidentical-transplantation-zometa-for-pediatric-hematologic-malignancies-and-solid-tumors/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/far-rms-an-overarching-study-for-children-and-adults-with-frontline-and-relapsed-rhabdomyosarcoma-far-rms/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/investigating-safety-tolerability-efficacy-and-pk-of-olaparib-in-paediatric-patients-with-solid-tumours/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/mt2004-30-tomotherapy-for-solid-tumors/ 2026-06-04T16:23:29+00:00 https://www.reforms-project.org.uk/clinical-trial/efficacy-and-safety-of-radiotherapy-combined-with-apatinib-mesylate-in-the-treatment-of-rhabdomyosarcoma-in-children/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/pilot-study-of-expanded-activated-haploidentical-natural-killer-cell-infusions-for-sarcomas-nkexpsarc/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/targeted-therapy-directed-by-genetic-testing-in-treating-pediatric-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphomas-or-histiocytic-disorders-the-pediatric-match-scre/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/ulixertinib-in-treating-patients-with-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-disorders-with-mapk-pathway-mutations-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/ensartinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-disorders-with-alk-or-ros1-genomic-alterations-a-pediatric-match-treatment-tria/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/selpercatinib-for-the-treatment-of-advanced-solid-tumors-lymphomas-or-histiocytic-disorders-with-activating-ret-gene-alterations-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/erdafitinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-disorders-with-fgfr-mutations-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/tipifarnib-for-the-treatment-of-advanced-solid-tumors-lymphoma-or-histiocytic-disorders-with-hras-gene-alterations-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:35+00:00 https://www.reforms-project.org.uk/clinical-trial/ivosidenib-in-treating-patients-with-advanced-solid-tumors-lymphoma-or-histiocytic-disorders-with-idh1-mutations-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/larotrectinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-disorders-with-ntrk-fusions-a-pediatric-match-treatment-trial/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-1-dose-escalating-study-of-mm-398-irinotecan-sucrosofate-liposome-injection-plus-intravenous-cyclophosphamide-in-recurrent-or-refractory-pediatric-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/flavored-oral-irinotecan-val-413-orotecan-given-with-temozolomide-for-treatment-of-recurrent-pediatric-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/enoblituzumab-mga271-in-children-with-b7-h3-expressing-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/vandetanib-and-everolimus-in-treating-patients-with-advanced-or-metastatic-cancer/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/pazit-study-for-children-and-young-adults-with-relapsed-or-refractory-sarcoma/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/radiolabeled-mab-therapy-in-patients-with-refractory-recurrent-or-advanced-cns-or-leptomeningeal-cancer/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/reduced-intensity-haploidentical-bmt-for-high-risk-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/mr-guided-high-intensity-focused-ultrasound-hifu-on-pediatric-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-2-stir-trial-haploidentical-transplant-and-donor-natural-killer-cells-for-solid-tumors-stir/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/cabozantinib-s-malate-in-treating-younger-patients-with-recurrent-refractory-or-newly-diagnosed-sarcomas-wilms-tumor-or-other-rare-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-lenvatinib-in-combination-with-everolimus-in-recurrent-and-refractory-pediatric-solid-tumors-including-central-nervous-system-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/study-evaluating-the-safety-and-efficacy-of-eribulin-mesilate-in-combination-with-irinotecan-hydrochloride-in-children-with-refractory-or-recurrent-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-i-study-of-lyso-thermosensitive-liposomal-doxorubicin-and-mr-hifu-for-pediatric-refractory-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/exatecan-mesylate-in-treating-children-with-relapsed-or-refractory-rhabdomyosarcoma/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/gallium-nitrate-in-treating-children-with-brain-tumor-neuroblastoma-rhabdomyosarcoma-non-hodgkins-lymphoma-or-refractory-solid-tumors/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/holmium-ho-166-dotmp-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-metastatic-ewings-sarcoma-or-rhabdomyosarcoma-that-has-spread-to-the-bone/ 2026-06-04T16:23:36+00:00 https://www.reforms-project.org.uk/clinical-trial/liposomal-doxorubicin-in-treating-children-with-refractory-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/peripheral-stem-cell-transplantation-plus-chemotherapy-in-treating-patients-with-malignant-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/temozolomide-plus-peripheral-stem-cell-transplantation-in-treating-children-with-newly-diagnosed-malignant-glioma-or-recurrent-cns-or-other-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/cryosurgery-in-treating-patients-with-soft-tissue-sarcoma/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-ii-study-of-topotecan-and-ifosfamide-in-pediatric-patients-with-relapsed-or-refractory-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/randomized-phase-ii-study-of-two-cross-over-sequences-comprising-outpatient-chemotherapies-vinorelbine-cyclophosphamide-r1-and-temozolomide-etoposide-r2-for-relapsed-or-refractory-solid-tumors-i/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/allogeneic-hematopoietic-stem-cell-transplantation-rice/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/continuous-hyperthermic-peritoneal-perfusion-chpp-with-cisplatin-for-children-with-peritoneal-cancer/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/tanespimycin-in-treating-young-patients-with-recurrent-or-refractory-leukemia-or-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/a-pilot-study-of-tumor-specific-peptide-vaccination-and-il-2-with-or-without-autologous-t-cell-transplantation-in-recurrent-pediatric-sarcomas/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-ly2940680-in-pediatric-medulloblastoma-or-rhabdomyosarcoma/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-ii-study-of-everolimus-in-children-and-adolescents-with-refractory-or-relapsed-rhabdomyosarcoma-and-other-soft-tissue-sarcomas/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/disulfiram-with-copper-gluconate-and-liposomal-doxorubicin-in-treatment-refractory-sarcomas/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/neoadjuvant-dual-checkpoint-inhibition-and-cryoablation-in-relapsed-refractory-pediatric-solid-tumors/ 2026-06-04T16:23:37+00:00 https://www.reforms-project.org.uk/clinical-trial/multicohort-trial-of-trabectedin-and-low-dose-radiation-therapy-in-advanced-metastatic-sarcomas-synergias/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-surufatinib-in-combination-with-gemcitabine-in-pediatric-adolescent-and-young-adult-patients-with-recurrent-or-refractory-solid-tumors/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/131i-omburtamab-for-the-treatment-of-central-nervous-system-leptomeningeal-neoplasms-in-children-and-young-adults/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/elimusertib-for-the-treatment-of-relapsed-or-refractory-solid-tumors/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-cabozantinib-as-a-maintenance-agent-to-prevent-progression-or-recurrence-in-high-risk-pediatric-solid-tumors/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-efficacy-and-safety-of-ribociclib-lee011-in-combination-with-topotecan-and-temozolomide-totem-in-pediatric-patients-with-relapsed-or-refractory-neuroblastoma-and-other-solid-tumors/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/doxorubicin-hydrochloride-liposome-combined-with-irinotecan-ai-regimen-versus-vit-regimen-in-the-treatment-of-first-relapsed-and-refractory-pediatric-rhabdomyosarcoma-a-prospective-open-label-ran/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-trial-of-nivolumab-in-pediatric-patients-with-malignant-solid-tumors-or-hodgkin-lymphoma/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/9-ing-41-in-pediatric-patients-with-refractory-malignancies/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-to-test-the-safety-and-efficacy-of-the-drug-larotrectinib-for-the-treatment-of-tumors-with-ntrk-fusion-in-children-scout/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/durvalumab-in-pediatric-and-adolescent-patients/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-erdafitinib-in-participants-with-advanced-solid-tumors-and-fibroblast-growth-factor-receptor-fgfr-gene-alterations-ragnar/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/vitas-atezolizumab-in-combination-with-chemotherapy-for-pediatric-relapsed-refractory-solid-tumors/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-2-basket-trial-of-nab-sirolimus-in-patients-with-malignant-solid-tumors-with-pathogenic-alterations-in-tsc1-tsc2-genes-precision-1/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-to-evaluate-tovorafenib-in-pediatric-and-young-adult-patients-with-relapsed-or-progressive-low-grade-glioma-and-advance-solid-tumors-firefly-1/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-the-safety-and-pharmacokinetics-of-venetoclax-in-pediatric-and-young-adult-patients-with-relapsed-or-refractory-malignancies/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-2-cab-axl-adc-safety-and-efficacy-study-in-adult-and-adolescent-patients-with-sarcoma/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/jcog1802-a-randomized-phase-ii-trial-of-2nd-line-treatment-for-advanced-soft-tissue-sarcoma-comparing-trabectedin-eribulin-and-pazopanib-2nd-step/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/study-to-investigate-safety-pharmacokinetic-pk-pharmacodynamic-pd-and-clinical-activity-of-trametinib-in-subjects-with-cancer-or-plexiform-neurofibromas-and-trametinib-in-combination-with-dabraf/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/ex-vivo-drug-sensitivity-testing-and-multi-omics-profiling/ 2026-06-04T16:23:44+00:00 https://www.reforms-project.org.uk/clinical-trial/her2-chimeric-antigen-receptor-car-t-cells-in-combination-with-checkpoint-blockade-in-patients-with-advanced-sarcoma/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-to-learn-about-the-study-medicine-called-pf-07799933-in-people-with-advanced-solid-tumors-with-braf-alterations/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/tapur-testing-the-use-of-food-and-drug-administration-fda-approved-drugs-that-target-a-specific-abnormality-in-a-tumor-gene-in-people-with-advanced-stage-cancer-tapur/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-fore8394-as-a-single-agent-in-patients-with-advanced-unresectable-solid-tumors/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/gd2-sada177lu-dota-complex-in-patients-with-solid-tumors-known-to-express-gd2/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/sirolimus-in-combination-with-metronomic-chemotherapy-in-children-with-high-risk-solid-tumors-aflacst1903/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/the-prospective-trial-of-patient-proposed-healthcare-services-with-multiple-targeted-agent-based-on-the-result-of-gene-profiling-by-multigene-panel-test-believe/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/tiragolumab-and-atezolizumab-for-the-treatment-of-relapsed-or-refractory-smarcb1-or-smarca4-deficient-tumors/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/surufatinib-in-patients-with-osteosarcoma-and-soft-tissue-sarcoma/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/chidamide-combined-with-toripalimab-in-sarcoma/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-i-study-of-vorinostat-and-bortezomib-in-children-with-refractory-of-recurrent-solid-tumors-including-cns-tumors-and-lymphomas/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/targeting-cd276-b7-h3-positive-solid-tumors-by-4scar-276/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/tas-117-in-patients-with-advanced-solid-tumors-harboring-germline-pten-mutations/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/clinical-study-of-vorinostat-in-combination-with-etoposide-in-pediatric-patients-21-years-at-diagnosis-with-refractory-solid-tumors/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/personalized-vaccination-in-fusion-sarcoma-patients-pervision-pervision/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/european-proof-of-concept-therapeutic-stratification-trial-of-molecular-anomalies-in-relapsed-or-refractory-tumors-esmart/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/c7r-gd2-cart-cells-for-patients-with-relapsed-or-refractory-neuroblastoma-and-other-gd2-positive-cancers-gail-n/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/combination-immunotherapy-targeting-sarcomas/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/determine-trial-treatment-arm-03-entrectinib-in-adult-paediatric-and-teenage-young-adults-and-paediatric-patients-with-ros1-gene-fusion-positive-cancers-determine/ 2026-06-04T16:23:54+00:00 https://www.reforms-project.org.uk/clinical-trial/determine-determining-extended-therapeutic-indications-for-existing-drugs-in-rare-molecularly-defined-indications-using-a-national-evaluation-platform-trial-master-screening-protocol-determine/ 2026-06-04T16:23:55+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-entrectinib-rxdx-101-in-children-and-adolescents-with-locally-advanced-or-metastatic-solid-or-primary-cns-tumors-and-or-who-have-no-satisfactory-treatment-options-startrk-ng/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-repotrectinib-tpx-0005-in-patients-with-advanced-solid-tumors-harboring-alk-ros1-or-ntrk1-3-rearrangements-trident-1/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-fcn-011-in-patients-with-advanced-solid-tumor%ef%bc%88phase-i%ef%bc%89and-ntrk-fusion-positive-advanced-solid-tumor-%ef%bc%88phase-ii%ef%bc%89/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/larotrectinib-for-the-treatment-of-ntrk-amplification-positive-locally-advanced-or-metastatic-solid-tumors/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-i-iia-trial-of-hmbd-001-in-advanced-her3-positive-solid-tumours/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/clinical-trial-of-gaia-102-for-refractory-relapse-neuroblastomas-and-other-malignant-pediatric-solid-tumors/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-nvl-655-in-patients-with-advanced-nsclc-and-other-solid-tumors-harboring-alk-rearrangement-or-activating-alk-mutation-alkove-1/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/the-evaluation-of-pc14586-in-patients-with-advanced-solid-tumors-harboring-a-tp53-y220c-mutation-pynnacle/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/nk-white-blood-cells-and-interleukin-in-children-and-young-adults-with-advanced-solid-tumors/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-atrn-119-in-patients-with-advanced-solid-tumors-aboya-119/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-selpercatinib-loxo-292-in-participants-with-advanced-solid-tumors-ret-fusion-positive-solid-tumors-and-medullary-thyroid-cancer-libretto-001-libretto-001/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-kb-0742-in-participants-with-relapsed-or-refractory-solid-tumors-including-platinum-resistant-high-grade-serous-ovarian-cancer-hgsoc/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-rp-6306-alone-or-in-combination-with-rp-3500-or-debio-0123-in-patients-with-advanced-solid-tumors-mythic/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/silmitasertib-cx-4945-in-combination-with-chemotherapy-for-relapsed-refractory-solid-tumors/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/study-of-autologous-tumor-infiltrating-lymphocytes-in-pediatric-adolescent-and-young-adult-participants/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/alpha-beta-t-and-b-cell-depletion-with-zoledronic-acid-for-solid-tumors/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/clinical-trial-of-vim-with-vit-in-children-with-relapsed-and-refractory-soft-tissue-sarcoma/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/durvalumab-and-tremelimumab-for-pediatric-malignancies/ 2026-06-04T16:24:04+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-evaluating-the-safety-tolerability-pharmacokinetics-and-preliminary-activity-of-idasanutlin-in-combination-with-either-chemotherapy-or-venetoclax-in-treatment-of-pediatric-and-young-adult-pa/ 2026-06-04T16:24:05+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-i-trial-of-memory-t-cells-expressing-an-nkg2d-chimeric-antigen-receptor-in-children-adolescents-and-young-adults-with-advanced-sarcoma-car4sar/ 2026-06-04T16:24:05+00:00 https://www.reforms-project.org.uk/clinical-trial/improving-public-cancer-care-by-implementing-precision-medicine-in-norway-impress-n/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-avapritinib-in-pediatric-patients-with-solid-tumors-dependent-on-kit-or-pdgfra-signaling/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/tumor-agnostic-precision-immuno-oncology-and-somatic-targeting-rational-for-you-tapistry-platform-study/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-evaluating-the-safety-pharmacokinetics-and-efficacy-of-alectinib-in-pediatric-participants-with-alk-fusion-positive-solid-or-cns-tumors/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-trial-to-determine-the-dose-and-evaluate-the-pk-of-lutetium-lu-177-edotreotide-therapy-in-pediatric-participants-with-sstr-positive-tumors-kinlet/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-i-dose-escalation-and-pharmacokinetics-clinical-trial-of-mitoxantrone-hydrochloride-liposome-in-children-with-relapsed-and-refractory-lymphoma-and-solid-tumors/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/regn2810-in-pediatric-patients-with-relapsed-refractory-solid-or-central-nervous-system-cns-tumors-and-safety-and-efficacy-of-regn2810-in-combination-with-radiotherapy-in-pediatric-patients-with-n/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-oral-loxo-292-selpercatinib-in-pediatric-participants-with-advanced-solid-or-primary-central-nervous-system-cns-tumors-libretto-121/ 2026-06-04T16:24:14+00:00 https://www.reforms-project.org.uk/clinical-trial/optimal-precision-therapies-to-customise-care-in-childhood-and-adolescent-cancer/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-to-assess-naporafenib-eras-254-administered-with-trametinib-in-patients-with-ras-q61x-mutations-seacraft-1/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/tovorafenib-day101-monotherapy-or-in-combination-with-other-therapies-for-patients-with-melanoma-and-other-solid-tumors/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/day101-in-gliomas-and-other-tumors/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/tazemetostatnivo-ipi-in-ini1-neg-smarca4-def-tumors/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-1b-of-crizotinib-either-in-combination-or-as-single-agent-in-pediatric-patients-with-alk-ros1-or-met-positive-malignancies-study-itcc-053/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/feasibility-clinical-trial-of-the-combination-of-alocelyvir-with-chemotherapy-and-radiotherapy-for-the-treatment-of-children-and-adolescents-with-relapsed-or-refractory-extracranial-solid-tumors/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/efficacy-of-tislelizumab-administered-in-combination-with-eribulin-and-anlotinib-for-patients-pts-with-advanced-adult-soft-tissue-sarcoma-teasts/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/investigator-initiated-clinical-trial-of-nivolumab-monotherapy-for-rare-cancers-roll-trial/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/investigator-initiated-clinical-trial-of-nivolumab-monotherapy-for-rare-cancers-with-mismatch-repair-deficiency-rock-trial/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/brigatinib-in-pediatric-and-young-adult-patients-with-alk-alcl-imt-or-other-solid-tumors-briga-ped/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/a-study-of-cobolimab-plus-dostarlimab-in-pediatric-and-young-adult-participants-with-cancer/ 2026-06-04T16:24:15+00:00 https://www.reforms-project.org.uk/clinical-trial/evaluation-of-the-efficacy-and-safety-of-pazopanib-in-combination-with-tgi-civ-for-recurrent-or-refractory-rhabdomyosarcoma-in-children-or-adolescents/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/peel-224-vincristine-and-temozolomide-in-pediatric-solid-tumors-peel-224/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/phase-1-2-trial-to-evaluate-the-safety-and-efficacy-of-peel-224-in-combination-with-vincristine-and-temozolomide-in-adolescents-and-young-adults-with-relapsed-or-refractory-sarcomas/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/fgfr4-chimeric-antigen-receptor-car-t-cells-in-children-and-young-adults-with-recurrent-or-refractory-rhabdomyosarcoma/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/chemo-immunotherapy-in-patients-under-18-years-of-age-with-bone-and-soft-tissue-sarcomas-followthedin/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/exploratory-study-of-personalized-mrna-vaccine-in-patients-with-refractory-rhabdomyosarcoma/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/car-t-cells-for-children-teenagers-and-young-adults-with-sarcoma/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/determine-trial-treatment-arm-01-alectinib-in-adult-paediatric-and-teenage-young-adult-patients-with-alk-positive-cancers-determine/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/determine-trial-treatment-arm-02-atezolizumab-in-adult-paediatric-and-teenage-young-adult-patients-with-cancers-with-high-tumour-mutational-burden-tmb-or-microsatellite-instability-high/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/determine-trial-treatment-arm-04-trastuzumab-in-combination-with-pertuzumab-in-adult-paediatric-and-teenage-young-adult-patients-with-cancers-with-her2-amplification-or-activating-mutations/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/her2-chimeric-antigen-receptor-expressing-t-cells-in-advanced-sarcoma/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/glypican-3-specific-chimeric-antigen-receptor-expressed-in-t-cells-for-patients-with-pediatric-solid-tumors-gap-gap/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/anti-gd2-car-t-cells-in-pediatric-patients-affected-by-high-risk-and-or-relapsed-refractory-neuroblastoma-or-other-gd2-positive-solid-tumors/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/a-phase-i-trial-of-t-cells-expressing-an-anti-gd2-chimeric-antigen-receptor-in-children-and-young-adults-with-gd2-solid-tumors/ 2026-06-04T16:24:25+00:00 https://www.reforms-project.org.uk/clinical-trial/stratified-medicine-paediatrics-2-developing-genetic-tests-to-diagnose-monitor-and-guide-treatment-decisions-for-children-and-young-people-whose-cancer-has-returned/ 2026-06-04T16:24:25+00:00